Optoceutics ApS: Financial statements 2020
CVR: 39769689
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Optoceutics ApS (CVR 39769689) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -131,718 and a net result of DKK -506,333. Equity in the 2020 report amounted to DKK 16,247,893. The solvency ratio was 59.6%. The company had 6 employees in the financial year.
- Gross Profit
- DKK -131,718
- Profit/Loss
- DKK -506,333
- Equity
- DKK 16,247,893
- Total Assets
- DKK 27,269,198
- Employees
- 6
Official annual report
How creditworthy is Optoceutics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Optoceutics ApS has published its interim report for the period August 8, 2018 – December 31, 2019.
As of September 1, 2020, KPMG P/S has been appointed auditor of Optoceutics ApS.
As of September 1, 2020, Kaare Agerholm Danielsen has joined the board of directors of Optoceutics ApS.
As of January 31, 2020, Vjack Holding ApS is registered as an owner of Optoceutics ApS with an ownership share of 5%.
About Optoceutics ApS
Optoceutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Optoceutics IVS. The management consists of Ngoc Mai Thi Nguyen and Marcus Schultz Carstensen. The board consists of Jes Broeng (chair), Kaare Agerholm Danielsen, Marcus Schultz Carstensen and Ngoc Mai Thi Nguyen. The company's owners include Vjack Holding ApS, M. S. C. HOLDING ApS and Danielsen 2 ApS. According to the 2025 annual report, the company had an average of 7 employees. In 2025, the company reported a gross profit of DKK -2,585,556 and a net result of DKK -8,736,152 compared with DKK -9,184,625 the year before. Equity in the 2025 report amounted to DKK 32,320,160.